All Title Author
Keywords Abstract

In Silico Evaluation of Anti-Malarial Agents from Hoslundia opposita as Inhibitors of Plasmodium falciparum Lactate Dehydrogenase (PfLDH) Enzyme

DOI: 10.4236/cmb.2016.62002, PP. 23-32

Keywords: PfLDH, Hoslundin, Hoslundal, Hoslunddiol, Anti-Malarial, Docking

Full-Text   Cite this paper   Add to My Lib


Malaria has continued to be a health and economic problem in Africa and the world at large. Many anti-malarial drugs have been rendered ineffective due to the emergence of resistant strains of Plamodium falciparum. A key malaria parasite enzyme in glycolytic pathway, P. falciparum lactate dehydrogenase (PfLDH) is specially targeted for anti-malarial drugs development. Thus, the aim of this investigation was to determine the in silico inhibition effects of antimalarial compounds from Hoslundia opposita Vahl. namely hoslundin, hoslundal and hoslunddiol on PfLDH enzyme. The compounds were docked to the three-dimensional structure of PfLDH as enzyme using AutoDock Vina in PyRx virtual screening software. Binding affinity and position of the inhibitors were evaluated using PyMol software. The PfLDH enzyme showed two binding sites: the cofactors binding site (Site A) and secondary binding site (Site B). In the absence of the cofactor all ligands showed higher affinity than NADH, and were bound to the cofactors binding site (Site A). When docked in the presence of the cofactor, site B was the preferred binding site. Binding to cofactor site with higher binding energy than NADH suggests that these ligands could act as preferential competitive inhibitors of PfLDH. However, the binding to site B also suggests that they may be non-competitive allosteric inhibitors. Amino acid residues Gly99, Asn140, Phe100 and Thr97 were indicated to form hydrogen bonds with Hoslundin. Hoslunddiol showed hydrogen bonding with Thr97 and Met30, while Hoslundal formed hydrogen bond with Thr101 and Asn140.


[1]  World Health Organization (2014) World Malaria Report. World Health Organization, Geneva.
[2]  Hasan, A., Mazumder, H.H., Chowdhury, A.S., Datta, A. and Khan A. (2015) Molecular-Docking Study of Malaria Drug Target Enzyme Transketolase in Plasmodium falciparum 3D7 Portends the Novel Approach to Its Treatment. Source Code for Biology and Medicine, 10, 1-14.
[3]  Penna-Coutinho, J., Cortopassi, W.A., Oliveira, A.A., Franca, T.C.C. and Krettli, A.U. (2011) Antimalarial Activity of Potential Inhibitors of Plasmodium falciparum Lactate Dehydrogenase Enzyme Selected by Docking Studies. PLoS ONE, 6, e21237.
[4]  Waingeh, V.F., Groves, A.T. and Eberle, J.A. (2013) Binding of Quinoline-Based Inhibitors to Plasmodium falciparum Lactate Dehydrogenase: A Molecular Docking Study. Open Journal of Biophysics, 3, 285-290.
[5]  Chinsembu, K.C. (2015) Plants as Antimalarial Agents in Sub-Saharan Africa. Acta Tropica, 152, 32-48.
[6]  Navarro, M., Castro, W., Madamet, M., Amalvict, R., Benoit, N. and Pradines B. (2014) Metal-Chloroquine Derivatives as Possible Anti-Malarial Drugs: Evaluation of Anti-Malarial Activity and Mode of Action. Malaria Journal, 13, 1-8.
[7]  Silva, N.S.R., Gonçalves, L.K.S., Duarte, J.L., Silva, J.S, Santos, C.F., Branga, F.S., Silva, R.C., Costa, J.S., Hage-Melim, L.I.S. and dos Santos C, B.R. (2014) Computational Analysis of Physicochemical, Pharmacokinetic and Toxicological Properties of Deoxyhypusine Synthase Inhibitors with Antimalarial Activity. Computational Molecular Bioscience, 4, 47-57.
[8]  de Souza, N.B., Carmo, A.M.L., da Silva, A.D., França, T.C.C. and Krettli, A.U. ( 2014) Antiplasmodial Activity of Chloroquine Analogs against Chloroquine-Resistant Parasites, Docking Studies and Mechanisms of Drug Action. Malaria Journal, 13, 1-12.
[9]  White, N.J. (2008) Plasmodium knowlesi: The Fifth Human Malaria Parasite. Clinical Infectious Diseases, 46, 172-173.
[10]  Srivastava, M., Singh, H. and Naik, P.K. (2010) Molecular Modeling Evaluation of the Antimalarial Activity of Artemisinin Analogues: Molecular Docking Rescoring using Prime/MM-GBSA Approach. Current Research Journal of Biological Science, 2, 83-102.
[11]  Sessions, R.B., Dewar, V., Clarke, A.R. and Holbrook, J.J. (1997) A mode of Plasmodium falciparum Lactate Dehydrogenase and Its Implications for the Design of Improved Antimalarials and the Enhanced Detection of Parasitaemia. Protein Engineering, 4, 301-306.
[12]  Prakash, N., Patel, S., Faldu, N.J., Ranjan, R. and Sudheer, D.V.N. (2010) Molecular Docking Studies of Antimalarial Drugs for Malaria. Journal of Computer Science & Systems Biology, 3, 070-073.
[13]  Bhat, H.R., Ghosh, S.K., Prakash, A., Gogoi, K. and Singh, U.P. (2012) In Vitro Antimalarial Activity and Molecular Docking Analysis of 4-Aminoquinolineclubbed 1,3,5-Triazine Derivatives. Letters in Applied Microbiology, 54, 483-486.
[14]  Boechat, N., Pinheiro, L.C.S., San-tos-Filho, O.A. and Silva, I.C. (2011) Design and Synthesis of New N-(5-Trifluoromethyl)-1H-1,2,4-triazol-3-yl Benzenesulfonamides as Possible Antimalarial Prototypes. Molecules, 16, 8083-8097.
[15]  Sharma, R.B. and Chetia, D. (2013) Docking Studies on Quinine Analogs for Plasmepsin-II of Malaria Parasir Using Bioinformatics Tools. International Journal of Pharmacy and Pharmaceutical Sciences, 5, 681-685.
[16]  Ngadjui, B.T., Ayafor, J.F., Sondengam, B.L., Connolly, J.D. and Rycroft, D.S. (1991) Hoslundin, Hoslundal and Hoslunddiol: Three New Flavonoids from the Twigs of Hoslundia opposita (Lamiaceae). Tetrahedron, 47, 3555-3564.
[17]  Nkunya, M.H.H. (2002) Natural Chemicals for Disease and Insect Management. Professorial Inaugural Lecture, University of Dar es Salaam, Dar es Salaam.
[18]  Salame, R., Cheikh-Ali, Z., Bories, C., Adiko, M., Poapon, E. and Champy, P. (2012) Pyrone and Unusually Furanone-Substituted Flavones from the Leaves of Hoslundia opposite. Planta Medica, 78, 1777-1779.
[19]  Sarker, S.D., Batholomew, B., Nash, R.J. and Robinson, N. (2000) 5-O-Methylhoslunding: An Unusual Flavonoid from Bidens pilosa (Asteraceae). Biochemical Systematics and Ecology, 28, 591-593.
[20]  Ngadjui, B.T., Ayafor, J.F., Sondengam, B.L., Connolly, J.D., Rycroft, D.S. and Tillequin, F. (1993) Oppositin and 5-O-Methylhoslundin, Pyrone-Substituted Flavonoids of Hoslundia opposite. Phytochemistry, 32, 1313-1315.
[21]  Murithi, C.K., Nguta, J.M. and Lukhoba, C.W. (2014) Anti-Malaria Activity and in Vivo Toxicity of Selected Medicinal Plants Naturalised in Kenya. International Journal of Education and Research, 2, 395-406.
[22]  Cameron, A., Ready, J., Tranter, R., Winter, V.J., Sessions, R.B., Brady, R.L., Vivas, L., Easton, A., Kendrick, H., Croft, S.L., Barros, D., Lavandera, J.L., Martin, J.J., Risco, F., Garcia-Ochoa, S., Gamo, F.J., Sanz, L., Leon, L., Ruiz, J.R., Gabarro, R., Mallo, A. and De Las Heras, F.G. (2004) Identification and Activity of a Series of Azole-Based Compounds with Lactate Dehydrogenase-Directed Anti-Malarial Activity. Journal of Biological Chemistry, 279, 31429-31439.
[23]  Muhammad, S.S. and Fatima, N. (2015) In Silico Analysis and Molecular Docking Studies of Potential Angiotensin-Converting Enzyme Inhibitor Using Quercetin Glycosides. Pharmacognosy Magazine, 11, 123-126.
[24]  Morris, G.M., Huey, R., Lindstrom, W., Sanner, M.F., Belew, R.K., Goodsell, D.S. and Olson, A.J. (2009) AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexiblity. Journal of Computational Chemistry, 30, 2785-2791.
[25]  Navya, A., Rayalu, J.D. and Devi, U.M.P. (2011) Docking Studies on Xanthones of Mangosteen as COX-2 Inhibitors. International Journal of Applied Biology and Pharmaceutical Technology, 2, 263-268.


comments powered by Disqus

Contact Us


微信:OALib Journal